| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.8% | 0.0% |
| Div Cover | 2.8 | n/a |
| Op Mrgn | 18.6% | n/a |
| ROCE | 61.9% |
| Latest | F'cast | |
|---|---|---|
| P/E | 43.4 | n/a |
| PEG | 2.1 | n/a |
| Pr/Revenue | 6.7 | n/a |
| Pr/Book | 10.3 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 11.8% | n/a |
| PBT | 40.6% | n/a |
| EPS | 20.7% | n/a |
| DPS | 5.1% | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Sep-21 | 787.40 | 96.60 | 85.20p | 33.4 | 0.7 | +51% | 42.60p | 1.5% |
| 30-Sep-22 | 1,012.80 | 129.50 | 107.50p | 21.6 | 0.8 | +26% | 53.80p | 2.3% |
| 30-Sep-23 | 1,200.30 | 155.60 | 90.80p | 33.1 | n/a | -16% | 56.50p | 1.9% |
| 30-Sep-24 | 1,363.40 | 176.60 | 145.80p | 30.4 | 0.5 | +61% | 59.30p | 1.3% |
| 30-Sep-25 | 1,524.50 | 248.30 | 176.00p | 30.1 | 1.4 | +21% | 62.30p | 1.2% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Director/PDMR Shareholding | 22-Dec-2025 | 07:00 | RNS |
| Holding(s) in Company | 19-Dec-2025 | 13:33 | RNS |
| Drug shares on a high | 19-Nov-2006 | Scotland on Sunday |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 7,200.00p |
| Change Today | 65.00p |
| % Change | 0.91 % |
| 52 Week High | 7,710.00 |
| 52 Week Low | 5,015.00 |
| Volume | 392,119 |
| Shares Issued | 134.32m |
| Market Cap | £9,671m |
| RiskGrade | 165 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 28-May-26 | 15-Jan-26 |
| Paid | 12-Jun-26 | 30-Jan-26 |
| Amount | 19.10p | 44.10p |
| Time | Volume / Share Price |
| 16:47 | 9,160 @ 7,180.57p |
| 16:39 | 1,399 @ 7,200.00p |
| 16:35 | 4,793 @ 7,200.00p |
| 16:35 | 562 @ 7,200.00p |
| 16:35 | 309 @ 7,200.00p |
You are here: research